151 related articles for article (PubMed ID: 2109450)
1. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: circulating lymphocytes that express plasma cell antigens.
Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Gonchoroff NJ; Garton JP; Kyle RA
Blood; 1984 Aug; 64(2):352-6. PubMed ID: 6611178
[TBL] [Abstract][Full Text] [Related]
3. Surface expression of human myeloma cells: an analysis using a panel of monoclonal antibodies.
Katagiri S; Yonezawa T; Tamaki T; Kanayama Y; Kuyama J; Ohnishi M; Tsubakio T; Kurata Y; Tarui S
Acta Haematol; 1984; 72(6):372-8. PubMed ID: 6442520
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
5. B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy.
Chan CS; Wormsley SB; Pierce LE; Peter JB; Schechter GP
Am J Hematol; 1990 Feb; 33(2):101-9. PubMed ID: 2301368
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
7. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma.
Jensen GS; Belch AR; Mant MJ; Ruether BA; Yacyshyn BR; Pilarski LM
Am J Hematol; 1993 May; 43(1):29-36. PubMed ID: 7686332
[TBL] [Abstract][Full Text] [Related]
8. Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion.
Hamilton MS; Ball J; Bromidge E; Franklin IM
Br J Haematol; 1991 May; 78(1):60-5. PubMed ID: 2043483
[TBL] [Abstract][Full Text] [Related]
9. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
10. Immunological phenotype of neoplasms involving the B cell in the last step of differentiation.
San Miguel JF; Caballero MD; Gonzalez M; Zola H; Lopez Borrasca A
Br J Haematol; 1986 Jan; 62(1):75-83. PubMed ID: 3080019
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
Menke DM; Horny HP; Griesser H; Atkinson EJ; Kaiserling E; Kyle RA
J Clin Pathol; 1998 Jun; 51(6):432-7. PubMed ID: 9771441
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell antigens in human multiple myeloma.
Mackenzie MR; Paglieroni TG
J Lab Clin Med; 1977 May; 89(5):1009-17. PubMed ID: 67161
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
15. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens.
Jackson N; Ling NR; Ball J; Bromidge E; Nathan PD; Franklin IM
Clin Exp Immunol; 1988 Jun; 72(3):351-6. PubMed ID: 3048803
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells.
Gazitt Y; Or R; Mumcuoglu M; Slavin S
Bone Marrow Transplant; 1987 Dec; 2(4):427-33. PubMed ID: 3332190
[TBL] [Abstract][Full Text] [Related]
18. Two distinct human myeloma cell lines originating from one patient with myeloma.
Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S
Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660
[TBL] [Abstract][Full Text] [Related]
19. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
20. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
